A Cancer Conundrum: Too Many Drug Trials, Too Few Patients
The New York Times
There are too many experimental cancer drugs in too many clinical trials, and not enough patients to test them on. Seeker Health helps drug developers differentiate and engage patients.
The Anger of Cancer by Susan Gubar
"At some level, most of these patients probably know that their anger is a deflection of their misery at the indignities and suffering inflicted by cancer or its treatments."
Parents of Children with Rare Diseases Find Hope in For-Profit Companies
"Instead of raising money and awareness by setting up a nonprofit foundation, a more typical route, she opted to start a for-profit company to seek treatments, if not a cure."
Dear Doctors: Please Do Not Confuse Your Medical Degree with my Google Search
"Now, I know I don’t have a medical degree to match my doctor’s. But, I do have a few other things going for me."
Catalog of DNA helps find roots of rare diseases
Better accuracy in identifying the genetic cause of a person’s disease provides a “clear and direct benefit to patients."
Toward Targeted Therapies for Autoimmune Disorders
Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.
Battling the Stress of Living with Chronic Illness
You can take steps to maximize your quality of life and minimize the challenges of living with a long-term illness. Use the following strategies to help you cope and regain control.
Whom Do You Tell When You’re Sick? Maybe Everyone You Know
People used to keep medical conditions private, but “a tweet-length piece of information can be the difference between life and death,” says a doctor.